共有 50 笔近期内部人交易记录记录，涉及 Cerevel Therapeutics Holdings, Inc. (CERE), 包括 20 笔买入 和 29 笔卖出. 内部人买入总额为 RSU 奖励 内部人卖出总额为 $4.2B.
近期活跃的重要内部人包括 Pfizer Inc, Bain Capital Investors Llc, Patrick Deval L. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — CERE
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-08-01 |
Pfizer Inc |
Other: Former 10% Owner |
要约收购（卖出） |
27,349,211 |
$45.00 |
$1.23B |
- |
| 2024-08-01 |
Bain Capital Investors Llc |
10 Percent Owner |
股份退回 |
65,679,781 |
$45.00 |
$2.96B |
- |
| 2024-08-01 |
Patrick Deval L |
Director |
股份退回 |
49,794 |
- |
- |
- |
| 2024-08-01 |
Riedel Norbert G |
Director |
股份退回 |
95,242 |
- |
- |
- |
| 2024-08-01 |
Coles N Anthony |
Director |
股份退回 |
4,809,418 |
- |
- |
- |
| 2024-08-01 |
Dekkers Marijn E |
Director |
股份退回 |
95,242 |
- |
- |
- |
| 2024-08-01 |
Sulzberger Gabrielle |
Director |
股份退回 |
95,242 |
- |
- |
- |
| 2024-08-01 |
Renaud Ronald C Jr |
President & CEO |
股份退回 |
320,742 |
- |
- |
- |
| 2024-08-01 |
Giordano Douglas E. |
Director |
股份退回 |
95,242 |
- |
- |
- |
| 2024-08-01 |
Gordon Christopher R |
10 Percent Owner |
股份退回 |
80,189 |
- |
- |
- |
| 2024-08-01 |
Mckernan Ruth |
Director |
股份退回 |
92,986 |
- |
- |
- |
| 2024-08-01 |
Dipietro Kenneth |
Chief Human Resources Officer |
股份退回 |
63,905 |
- |
- |
- |
| 2024-08-01 |
Koppel Adam |
10 Percent Owner |
股份退回 |
80,189 |
- |
- |
- |
| 2024-08-01 |
Burgess Paul D. |
See Remarks |
股份退回 |
81,065 |
- |
- |
- |
| 2024-08-01 |
Akamine Scott |
Chief Legal Officer |
股份退回 |
59,171 |
- |
- |
- |
| 2024-08-01 |
Altschuller Susan |
Chief Financial Officer |
股份退回 |
81,065 |
- |
- |
- |
| 2024-08-01 |
Sanchez Ramiro |
Chief Medical Officer |
股份退回 |
87,573 |
- |
- |
- |
| 2024-08-01 |
Renger John |
Chief Scientific Officer |
股份退回 |
87,573 |
- |
- |
- |
| 2024-08-01 |
Bodenrader Mark |
See Remarks |
股份退回 |
24,852 |
- |
- |
- |
| 2024-08-01 |
Tregoning Kathleen |
See Remarks |
股份退回 |
59,171 |
- |
- |
- |
| 2024-07-01 |
Coles N Anthony |
Director |
知情卖出 |
25,000 |
$41.18 |
$1.03M |
25,928 |
| 2024-06-05 |
Patrick Deval L |
Director |
限制性股票授予 (RSU) |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Riedel Norbert G |
Director |
限制性股票授予 (RSU) |
10,461 |
- |
- |
56,553 |
| 2024-06-05 |
Coles N Anthony |
Director |
限制性股票授予 (RSU) |
10,290 |
- |
- |
25,928 |
| 2024-06-05 |
Dekkers Marijn E |
Director |
限制性股票授予 (RSU) |
10,461 |
- |
- |
42,283 |
| 2024-06-05 |
Sulzberger Gabrielle |
Director |
限制性股票授予 (RSU) |
10,461 |
- |
- |
58,876 |
| 2024-06-05 |
Giordano Douglas E. |
Director |
限制性股票授予 (RSU) |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Gordon Christopher R |
10 Percent Owner |
限制性股票授予 (RSU) |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Mckernan Ruth |
Director |
限制性股票授予 (RSU) |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Koppel Adam |
10 Percent Owner |
限制性股票授予 (RSU) |
10,461 |
- |
- |
13,743 |
| 2024-06-03 |
Coles N Anthony |
Director |
知情卖出 |
50,000 |
$40.61 |
$2.03M |
15,638 |
| 2024-05-10 |
Coles N Anthony |
Director |
知情卖出 |
50,000 |
$42.10 |
$2.11M |
15,638 |
| 2024-04-01 |
Coles N Anthony |
Director |
知情卖出 |
50,000 |
$42.33 |
$2.12M |
15,638 |
| 2024-03-04 |
Coles N Anthony |
Director |
知情卖出 |
50,000 |
$41.01 |
$2.05M |
15,638 |
| 2024-02-29 |
Coles N Anthony |
Director |
知情卖出 |
50,000 |
$41.16 |
$2.06M |
15,638 |
| 2024-02-20 |
Perceptive Advisors Llc |
Director |
赠与（送出） |
170,317 |
- |
- |
- |
| 2024-02-07 |
Coles N Anthony |
Director |
知情卖出 |
2,506 |
$41.54 |
$104.11K |
15,638 |
| 2024-02-07 |
Renger John |
Chief Scientific Officer |
知情卖出 |
2,161 |
$41.54 |
$89.78K |
6,370 |
| 2024-02-06 |
Coles N Anthony |
Director |
期权行权 |
15,440 |
- |
- |
18,144 |
| 2024-02-06 |
Renger John |
Chief Scientific Officer |
期权行权 |
5,020 |
- |
- |
8,531 |
| 2024-01-19 |
Renaud Ronald C Jr |
President & CEO |
限制性股票授予 (RSU) |
284,023 |
- |
- |
284,023 |
| 2024-01-19 |
Dipietro Kenneth |
Chief Human Resources Officer |
限制性股票授予 (RSU) |
63,905 |
- |
- |
63,905 |
| 2024-01-19 |
Burgess Paul D. |
See Remarks |
限制性股票授予 (RSU) |
81,065 |
- |
- |
81,065 |
| 2024-01-19 |
Akamine Scott |
Chief Legal Officer |
限制性股票授予 (RSU) |
59,171 |
- |
- |
59,171 |
| 2024-01-19 |
Altschuller Susan |
Chief Financial Officer |
限制性股票授予 (RSU) |
81,065 |
- |
- |
81,065 |
| 2024-01-19 |
Sanchez Ramiro |
Chief Medical Officer |
限制性股票授予 (RSU) |
87,573 |
- |
- |
87,573 |
| 2024-01-19 |
Renger John |
Chief Scientific Officer |
限制性股票授予 (RSU) |
87,573 |
- |
- |
87,573 |
| 2024-01-19 |
Bodenrader Mark |
See Remarks |
限制性股票授予 (RSU) |
24,852 |
- |
- |
24,852 |
| 2024-01-19 |
Tregoning Kathleen |
See Remarks |
限制性股票授予 (RSU) |
59,171 |
- |
- |
59,171 |
| 2024-01-02 |
Coles N Anthony |
Director |
知情卖出 |
50,000 |
$42.24 |
$2.11M |
2,704 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
